|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Mink Therapeutics, Inc. (INKT) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
33,511,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile MiNK Therapeutics is a clinical stage biopharmaceutical company engaged in the discovery, development and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Co.'s key product candidate, AGENT-797, is an off-the-shelf, allogeneic iNKT cell therapy. In addition, Co. is developing a pipeline of allogeneic iNKT programs. Co.'s key programs include a CAR-iNKT program targeting B-cell maturation antigen (BCMA), which it refers to as BCMA-CAR-iNKT, and a tumor stromal targeting CAR-iNKT program, which it refers to as stromal target-CAR-iNKT. These programs are both in preclinical development.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
250,706 |
666,494 |
| Total Buy Value |
$0 |
$0 |
$368,144 |
$817,474 |
| Total People Bought |
0 |
0 |
1 |
3 |
| Total Buy Transactions |
0 |
0 |
7 |
15 |
| Total Shares Sold |
0 |
0 |
0 |
100,000 |
| Total Sell Value |
$0 |
$0 |
$0 |
$94,850 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ryan Barbara |
Director |
– • – |
2022-12-01 |
4 |
A |
$2.61 |
$17,751 |
D/D |
6,801 |
20,351 |
|
- |
|
| Baldoni John |
Director |
– • – |
2022-12-01 |
4 |
A |
$2.61 |
$14,376 |
D/D |
5,508 |
16,482 |
|
- |
|
| Ryan Barbara |
Director |
– • – |
2022-09-15 |
4 |
A |
$2.62 |
$35,501 |
D/D |
13,550 |
13,550 |
|
- |
|
| Behner Peter |
Director |
– • – |
2022-09-15 |
4 |
A |
$2.62 |
$30,751 |
D/D |
11,737 |
11,737 |
|
- |
|
| Wiinberg Ulf |
Director |
– • – |
2022-09-15 |
4 |
A |
$2.62 |
$28,003 |
D/D |
10,688 |
10,688 |
|
- |
|
| Corvese Brian |
Director |
– • – |
2022-09-15 |
4 |
A |
$2.62 |
$35,753 |
D/D |
13,646 |
13,646 |
|
- |
|
| Baldoni John |
Director |
– • – |
2022-09-15 |
4 |
A |
$2.62 |
$28,752 |
D/D |
10,974 |
10,974 |
|
- |
|
| Wiinberg Ulf |
Director |
– • – |
2022-07-19 |
4 |
B |
$1.39 |
$23,209 |
D/D |
16,661 |
298,300 |
2.39 |
- |
|
| Wiinberg Ulf |
Director |
– • – |
2022-07-18 |
4 |
B |
$1.33 |
$4,438 |
D/D |
3,339 |
281,639 |
2.31 |
- |
|
| Agenus Inc |
10% Owner |
– – • |
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,451,958 |
26,332,958 |
|
- |
|
| Agenus Inc |
10% Owner |
– – • |
2021-10-19 |
4 |
B |
$12.00 |
$16,800,000 |
D/D |
1,400,000 |
20,881,000 |
2.45 |
- |
|
| Wiinberg Ulf |
Director |
– • – |
2021-10-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
278,300 |
|
- |
|
| Corvese Brian |
Director |
– • – |
2021-10-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
278,300 |
|
- |
|
| Klaskin Christine M |
TreasurerOfficer |
• – – |
2021-10-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
55,660 |
|
- |
|
| Armen Garo H |
Director |
– • – |
2021-10-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,226,400 |
|
- |
|
| Agenus Inc |
10% Owner |
– – • |
2021-10-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,481,000 |
|
- |
|
| Buell Jennifer |
See RemarksOfficer |
• • – |
2021-10-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
208,725 |
|
- |
|
67 Records found
|
|
Page 3 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
